Abstract: A magnetic band that is made of elastomeric resin material with magnets deposed therein is disclosed. The magnetic band optionally contains wires and also optionally contains holes at each end that may have grommets inserted into the holes. The magnetic band is used for a plurality of purposes including its ability to hold metallic magnetic items.

Abstract: A vehicle includes a pump having a swash plate tiltable about a swashplate tilt axis, wherein rotation of the swashplate changes the title angle and effects a change in volumetric displacement of the pump. A controller is operatively coupled to the swashplate to effect rotation of the swashplate, the controller including a processor and memory, and logic stored in the memory and executable by the processor, the logic configured to automatically control at least one vehicle characteristic independent of a user input command.

Abstract: There is provided systems and methods for pilot alertness and awareness of target aircraft and target obstacle that are flying within a proceeding flight path collision. Transmitted guiding sound signals consisting of three dimensional effects and tonal sounds are generated by a flight unit, and sent to the pilot's headset for the desired purpose of directing the pilot's head position to locate the target aircraft and target obstacle. The flight unit processes time of collision from received target aircraft broadcast, and contain at least GPS data and target obstacle information from stored navigational maps. The flight unit further receives the pilot's head position through means of a head tracker. Furthermore, the flight unit is able to perform the functions of, storing piloted flight information, voice language instruction, flight assisted notification, and communicating with one or multiple mobile devices such for the information to be displayed visually, and is upgradable remotely.

Abstract: Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases due to mutations in Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: Provided herein are compounds according to Formulas (I) or (II) and pharmaceutically acceptable salts thereof, and compositions comprising the same, for use in various methods, including treating cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease, osteoarthritis, idiopathic pulmonary fibrosis and neurological conditions/disorders/diseases.

Abstract: Disclosed is a method of producing a machining fixture for fixedly holding a workpiece during machining of that workpiece. The method comprises: providing an initial machining fixture comprising a plurality of receiving elements for receiving the workpiece to be machined; determining a datum, the datum being dependent upon the relative positions of the receiving elements; determining positions and orientations of one or more reference surfaces with respect to the datum; measuring the surface of the initial machining fixture with respect to the datum; and, thereafter, controlling machining apparatus with respect to the datum to machine the initial machining fixture to form the one or more reference surfaces, thereby producing the machining fixture.

Abstract: Disclosed is a method of producing an object, the method comprising: providing a workpiece comprising a plurality of attachment features for attaching the workpiece to a machining fixture; determining a datum, the datum being dependent upon the relative positions of the attachment features; measuring the surface of the workpiece with respect to the datum; providing the machining fixture; attaching, using the attachment features, the workpiece to the machining fixture; providing a digital model specifying the object including the attachment features; and, thereafter, using the measurements of the workpiece surface and the digital model, controlling machining apparatus with respect to the datum to machine the workpiece so as to produce the object as specified by the digital model.

Abstract: A forming belt for use in making a nonwoven substrate. The forming belt includes a first surface defining a plane of the first surface and an axis parallel to a longitudinal direction corresponding to a machine direction when in use. A plurality of discrete belt patterns can be ordered in sequential relationship with respect to the longitudinal direction. At least a majority of the plurality of discrete belt patterns can include a discrete belt pattern overall area, a first forming zone having a first pattern of three-dimensional raised elements extending outwardly from the plane of the first surface and a second forming zone having a second pattern of three-dimensional raised elements extending outwardly from the plane of the first surface. The first forming zone can have a first air permeability value and the second forming zone can have a second air permeability value. The first air permeability value can be different from the second air permeability value.

Abstract: A nonwoven substrate. The nonwoven substrate can have a first surface defining a plane of the first surface and a plurality of three-dimensional features extending outwardly from the plane of the first surface. The plurality of three-dimensional features can have a first three-dimensional feature having a first intensive property having a first value and a second three-dimensional feature having the first intensive property having a second value different from the first value. The nonwoven substrate can have an MD Fuzz Value of less than 0.25 mg/cm2 when tested according to the Fuzz Level Test herein.

Abstract: A vehicle switch module includes a sub-network having switches connected thereto and a sub-network controller in operative communication with the sub-network and the switches. Each switch includes a microprocessor programmed to generate switch messages that include address and switch logic state data. The sub-network controller transmits switch queries onto the sub-network to a number of switch addresses to determine a connection status and switch state of switches in the switch module and receives switch messages responsive to the queries from switches at addresses to which the switch queries were transmitted. The received switch messages verify the identity of a switch in the module and provide a switch state for the switch. The sub-network controller interprets the received switch messages and—based on the switch address and switch state data in the messages—controls operation of a vehicle output or load associated with each of the switches.

Abstract: Disclosed herein is a method and apparatus for hardware-accelerating various data quality checking operations. Incoming data streams can be processed with respect to a plurality of data quality check operations using offload engines (e.g., reconfigurable logic such as field programmable gate arrays (FPGAs)). Accelerated data quality checking can be highly advantageous for use in connection with Extract, Transfer, and Load (ETL) systems.

Abstract: Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: A securing mechanism for securing a computing device within a vehicle includes a first end and a second end. A top face and a bottom face extend from the first end to the second end, and the securing mechanism is folded such that the bottom face at the first end is proximate to the bottom face at the second end, defining a channel configured to receive a portion of a seatbelt of the vehicle. The securing mechanism also includes an attachment mechanism that is configured to attach the securing mechanism to the computing device. In various embodiments, the securing mechanism is attached to the computing device at a point below a center of gravity for the computing device.

Abstract: Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

Abstract: The present disclosure provides ?-diketones or analogs thereof, that activate Wnt/?-catenin signaling and thus treat or prevent diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries or spine injuries, brain atrophy/neurological disorders related to the differentiation and development of the central nervous system, including Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; otic disorders like cochlear hair cell loss; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, such as hair loss, hematopoiesis related diseases and tissue regeneration related diseases.

Abstract: A first user device transmits a first signal, and a second user device transmits a second signal. A processing unit receives the first signal and the second signal. The processing unit identifies the first user device as an active target and the second user device as an active tracking device based on a predefined rule set including a plurality of selection criteria.

Abstract: An apparatus adapted for presenting a sheet of media to an image transfer structure. The apparatus includes a registration baffle positioned in an offset relationship relative to the image transfer structure and a pre-transfer baffle assembly including a first baffle oppositely disposed to a second baffle, the pre-transfer assembly generally forms an “S” shape and is adapted for guiding the sheet of media from the registration baffle to the image transfer structure. The pre-transfer baffle assembly is arranged in a first position adapted for guiding the sheet of media toward the image transfer structure at an angle of less than ninety degrees, and the pre-transfer baffle automatically begins rotation to a second position as the sheet of media reaches a pre-determined position within a paper path.

Abstract: The invention relates to modified polymerase enzymes which exhibit improved incorporation of nucleotide analogues bearing substituents at the 3? position of the sugar moiety that are larger in size than the naturally occurring 3? hydroxyl group. Also described are methods of using the polymerases to incorporate nucleotides into polynucleotides, particularly in the context of DNA sequencing.

Abstract: The present application discloses a compound which is which activates Wnt/?-catenin signaling and thus treats or prevents diseases related to signal transduction, such as osteoporosis and osteoarthropathy; osteogenesis imperfecta, bone defects, bone fractures, periodontal disease, otosclerosis, wound healing, craniofacial defects, oncolytic bone disease, traumatic brain injuries related to the differentiation and development of the central nervous system, comprising Parkinson's disease, strokes, ischemic cerebral disease, epilepsy, Alzheimer's disease, depression, bipolar disorder, schizophrenia; eye diseases such as age related macular degeneration, diabetic macular edema or retinitis pigmentosa and diseases related to differentiation and growth of stem cell, comprising hair loss, hematopoiesis related diseases and tissue regeneration related diseases.

Abstract: Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.